Pituitary volume in schizophrenia spectrum disorders

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 301-307

  Romo Nava, F ^a,b,f   Hoogenboom, W S ^a   Pelavin, P E ^a   Alvarado, J L ^a   Bobrow, L H ^a   MacMaster, F P ^c   Keshavan, M ^d   McCarley, R W ^a,e   Shenton, M E ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF CALGARY   (Canada)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

First episode; MRI; Pituitary volume; Schizophrenia; Schizotypal

Indexed keywords

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; BRAIN SIZE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FIRST EPISODE SCHIZOPHRENIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROANATOMICAL TRACT TRACING; NUCLEAR MAGNETIC RESONANCE IMAGING; PITUITARY VOLUME; PRIORITY JOURNAL; SCHIZOPHRENIA SPECTRUM DISORDER; SCHIZOTYPAL PERSONALITY DISORDER; SEX DIFFERENCE; SOCIAL STATUS;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PINEAL GLAND; PITUITARY-ADRENAL SYSTEM; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

EID: 84875920590     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.02.024     Document Type: Article

References (54)

1. Anderson J.E., Wible C.G., McCarley R.W., Jakab M., Kasai K., Shenton M.E. An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr. Res. 2002, 58(2-3):123-134.
2. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl. 1989, (7):49-58.
3. Andreasen N.C., Arndt S., Miller D., Flaum M., Nopoulos P. Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update. Psychopathology 1995, 28(1):7-17.
4. Bouix S., Martin-Fernandez M., Ungar L., Nakamura M., Koo M.S., McCarley R.W., Shenton M.E. On evaluating brain tissue classifiers without a ground truth. NeuroImage 2007, 36(4):1207-1224.
5. Bradley A.J., Dinan T.G. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J. Psychopharmacol. 2010, 24(4 Suppl.):91-118.
6. Caruso C., Bottino M.C., Pampillo M., Pisera D., Jaita G., Duvilanski B., Seilicovich A., Lasaga M. Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation. Endocrinology 2004, 145(10):4677-4684.
7. de Kloet E.R., Oitzl M.S., Joels M. Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci. 1999, 22(10):422-426.
8. DeLisi L.E., Boccio A.M., Riordan H., Hoff A.L., Dorfman A., McClelland J., Kushner M., Van Eyl O., Oden N. Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res. 1991, 38(1):39-50.
9. DeLisi L.E., Sakuma M., Kushner M., Finer D.L., Hoff A.L., Crow T.J. Anomalous cerebral asymmetry and language processing in schizophrenia. Schizophr. Bull. 1997, 23(2):255-271.
10. Dickey C.C., McCarley R.W., Voglmaier M.M., Niznikiewicz M.A., Seidman L.J., Hirayasu Y., Fischer I., Teh E.K., Van Rhoads R., Jakab M., Kikinis R., Jolesz F.A., Shenton M.E. Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter. Biol. Psychiatry 1999, 45(11):1393-1402.
11. Dickey C.C., Shenton M.E., Hirayasu Y., Fischer I., Voglmaier M.M., Niznikiewicz M.A., Seidman L.J., Fraone S., McCarley R.W. Large CSF volume not attributable to ventricular volume in schizotypal personality disorder. Am. J. Psychiatry 2000, 157(1):48-54.
12. Dickey C.C., McCarley R.W., Xu M.L., Seidman L.J., Voglmaier M.M., Niznikiewicz M.A., Connor E., Shenton M.E. MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder. Schizophr. Res. 2007, 89(1-3):49-58.
13. Doraiswamy P.M., Potts J.M., Axelson D.A., Husain M.M., Lurie S.N., Na C., Escalona P.R., McDonald W.M., Figiel G.S., Ellinwood E.H., et al. MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am. J. Neuroradiol. 1992, 13(5):1295-1299.
14. Fujisawa I., Asato R., Nishimura K., Togashi K., Itoh K., Nakano Y., Itoh H., Hashimoto N., Takeuchi J., Torizuka K. Anterior and posterior lobes of the pituitary gland: assessment by 1.5T MR imaging. J. Comput. Assist. Tomogr. 1987, 11(2):214-220.
15. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry 2005, 58(5):417-423.
16. Grams A.E., Gempt J., Stahl A., Förschler A. Female Pituitary Size in Relation to Age and Hormonal Factors. Neuroendocrinology 2010, 92(2):128-132.
17. Hirayasu Y., Shenton M.E., Salisbury D.F., Dickey C.C., Fischer I.A., Mazzoni P., Kisler T., Arakaki H., Kwon J.S., Anderson J.E., Yurgelun-Todd D., Tohen M., McCarley R.W. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry 1998, 155(10):1384-1391.
18. Hirayasu Y., McCarley R.W., Salisbury D.F., Tanaka S., Kwon J.S., Frumin M., Snyderman D., Yurgelun-Todd D., Kikinis R., Jolesz F.A., Shenton M.E. Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Arch. Gen. Psychiatry 2000, 57(7):692-699.
19. Hirayasu Y., Shenton M.E., Salisbury D.F., McCarley R.W. Hippocampal and superior temporal gyrus volume in first-episode schizophrenia. Arch. Gen. Psychiatry 2000, 57(6):618-619.
20. Hirayasu Y., Tanaka S., Shenton M.E., Salisbury D.F., DeSantis M.A., Levitt J.J., Wible C., Yurgelun-Todd D., Kikinis R., Jolesz F.A., McCarley R.W. Prefrontal gray matter volume reduction in first episode schizophrenia. Cereb. Cortex 2001, 11(4):374-381.
21. Hollingshead A. Two Factor Index of Social Position 1965, Yale Station, New Haven.
22. Johnson M.P., Chamberlain M. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268. Neuropharmacology 2002, 43(5):799-808.
23. Jovicich J., Czanner S., Han X., Salat D., van der Kouwe A., Quinn B., Pacheco J., Albert M., Killiany R., Blacker D., Maguire P., Rosas D., Makris N., Gollub R., Dale A., Dickerson B.C., Fischl B. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 2009, 46(1):177-192.
24. Kaneko M., Yokoyama F., Hoshino Y., Takahagi K., Murata S., Watanabe M., Kumashiro H. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features. Neuropsychobiology 1992, 25(1):1-7.
25. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Spencer M.H., Yurgelun-Todd D.A., Kikinis R., Jolesz F.A., McCarley R.W. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2003, 60(8):766-775.
26. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
27. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry 1993, 50(10):781-788.
28. Lang C.H., Ajmal M. Metabolic, hormonal, and hemodynamic changes induced by metabotropic excitatory amino acid agonist (1S,3R)-ACPD. Am. J. Physiol. 1995, 268(4 Pt 2):R1026-R1033.
29. Lee C.U., Shenton M.E., Salisbury D.F., Kasai K., Onitsuka T., Dickey C.C., Yurgelun-Todd D., Kikinis R., Jolesz F.A., McCarley R.W. Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Arch. Gen. Psychiatry 2002, 59(9):775-781.
30. Lieberman J., Chakos M., Wu H., Alvir J., Hoffman E., Robinson D., Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry 2001, 49(6):487-499.
31. Lurie S.N., Doraiswamy P.M., Husain M.M., Boyko O.B., Ellinwood E.H., Figiel G.S., Krishnan K.R. In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J. Clin. Endocrinol. Metab. 1990, 71(2):505-508.
32. MacMaster F.P., El-Sheikh R., Upadhyaya A.R., Nutche J., Rosenberg D.R., Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophr. Res. 2007, 92(1-3):207-210.
33. MacMaster F.P., Keshavan M., Mirza Y., Carrey N., Upadhyaya A.R., El-Sheikh R., Buhagiar C.J., Taormina S.P., Boyd C., Lynch M., Rose M., Ivey J., Moore G.J., Rosenberg D.R. Development and sexual dimorphism of the pituitary gland. Life Sci. 2007, 80(10):940-944.
34. Mitropoulou V., Goodman M., Sevy S., Elman I., New A.S., Iskander E.G., Silverman J.M., Breier A., Siever L.J. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr. Res. 2004, 70(1):27-31.
35. Mondelli V., Dazzan P., Gabilondo A., Tournikioti K., Walshe M., Marshall N., Schulze K.K., Murray R.M., McDonald C., Pariante C.M. Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 2008, 33(7):1004-1012.
36. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
37. Pariante C.M. Pituitary volume in psychosis: the first review of the evidence. J. Psychopharmacol. 2008, 22(2 Suppl.):76-81.
38. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., Pantelis C. Pituitary volume in psychosis. Br. J. Psychiatry 2004, 185:5-10.
39. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., Fearon P., Orr K., Hutchinson G., Pantelis C., Velakoulis D., Jones P.B., Leff J., Murray R.M. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 2005, 30(10):1923-1931.
40. Pohl K.M., Bouix S., Nakamura M., Rohlfing T., McCarley R.W., Kikinis R., Grimson W.E., Shenton M.E., Wells W.M. A hierarchical algorithm for MR brain image parcellation. IEEE Trans. Med. Imaging 2007, 26(9):1201-1212.
41. Raine A. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu. Rev. Clin. Psychol. 2006, 2:291-326.
42. Sapolsky R.M. Stress and plasticity in the limbic system. Neurochem. Res. 2003, 28(11):1735-1742.
43. Sarkar D.K., Chaturvedi K., Oomizu S., Boyadjieva N.I., Chen C.P. Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 2005, 146(10):4179-4188.
44. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. Decreased pituitary volume in patients with bipolar disorder. Biol. Psychiatry 2001, 50(4):271-280.
45. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 1992, 327(9):604-612.
46. Siever L.J., Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am. J. Psychiatry 2004, 161(3):398-413.
47. Takahashi T., Suzuki M., Velakoulis D., Lorenzetti V., Soulsby B., Zhou S.Y., Nakamura K., Seto H., Kurachi M., Pantelis C. Increased pituitary volume in schizophrenia spectrum disorders. Schizophr. Res. 2009, 108(1-3):114-121.
48. Takahashi T., Zhou S.Y., Nakamura K., Tanino R., Furuichi A., Kido M., Kawasaki Y., Noguchi K., Seto H., Kurachi M., Suzuki M. Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(1):177-183.
49. Takahashi T., Kido M., Nakamura K., Furuichi A., Zhou S.Y., Kawasaki Y., Noguchi K., Seto H., Kurachi M., Suzuki M. Longitudinal MRI study of the pituitary volume in chronic schizophrenia: a preliminary report. Psychiatry Res. 2012, 202(1):84-87.
50. Tournikioti K., Tansella M., Perlini C., Rambaldelli G., Cerini R., Versace A., Andreone N., Dusi N., Balestrieri M., Malago R., Gasparini A., Brambilla P. Normal pituitary volumes in chronic schizophrenia. Psychiatry Res. 2007, 154(1):41-48.
51. Upadhyaya A.R., El-Sheikh R., MacMaster F.P., Diwadkar V.A., Keshavan M.S. Pituitary volume in neuroleptic-naive schizophrenia: a structural MRI study. Schizophr. Res. 2007, 90(1-3):266-273.
52. van den Pol A.N., Wuarin J.P., Dudek F.E. Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 1990, 250(4985):1276-1278.
53. Walker E.F., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 1997, 104(4):667-685.
54. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 2008, 4:189-216.